Roshni Kulkarni: The Hidden Cost of Underdiagnosed Bleeding Disorders
Roshni Kulkarni, Professor at Michigan State University, shared a post on LinkedIn:
”So glad that the financial impact of delayed diagnosis, under treatment is being recognized.
Thanks Sanjay Ahuja.”
Sanjay Ahuja, Chief Medical Officer at Indiana Hemophilia and Thrombosis Center, shared a post on LinkedIn։
”Women with bleeding disorders remain significantly underdiagnosed and undertreated.
Delays in diagnosis can extend for years, often resulting in repeated emergency visits, chronic anemia, lost productivity and avoidable procedures.
This is not simply a clinical issue. It is a systems and cost issue
Closing this gap for women is not only the right thing to do for patients – it is a high-value, cost-effective investment for any State.”
Stay updated with Hemostasis Today.
-
Jul 12, 2026, 12:30Reduced-Dose DOACs in GI Malignancies: Toward Personalized Anticoagulation
-
Jul 12, 2026, 08:50Where the Hemophilia Community Comes Together at ISTH 2026 – EAHAD
-
Jul 12, 2026, 08:2210 Posts Not To Miss from ISTH 2026, Part 1
-
Jul 12, 2026, 07:58Brian O Mahony: Could NXT-007 Minimize the Need for Perioperative FVIII
-
Jul 12, 2026, 07:50Shayan Mohammadmoradi: Connecting the Next Generation of Hemostasis Researchers at ISTH 2026
-
Jul 12, 2026, 07:42Alexandra Yakusheva: ThrombInnov Debuts at ISTH 2026 with a Focus on Translational Research
-
Jul 12, 2026, 07:34Wolfgang Miesbach: ISTH 2026 Explores the Next Generation of APS Diagnostics
-
Jul 12, 2026, 07:28Sara Zalghout: ISTH 2026 Highlights Progress in Thromboinflammation Research
-
Jul 12, 2026, 07:13Ekaterina Balaian: Finding Healing Through Art at ISTH 2026